{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:22:13Z","timestamp":1768706533689,"version":"3.49.0"},"reference-count":38,"publisher":"American Psychiatric Association Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,10,1]]},"DOI":"10.1176\/appi.ajp.160.10.1836","type":"journal-article","created":{"date-parts":[[2003,9,26]],"date-time":"2003-09-26T21:41:55Z","timestamp":1064612515000},"page":"1836-1841","source":"Crossref","is-referenced-by-count":87,"title":["Greater Availability of Brain Dopamine Transporters in Major Depression Shown by [<sup>99m<\/sup>Tc]TRODAT-1 SPECT Imaging"],"prefix":"10.1176","volume":"160","author":[{"given":"David J.","family":"Brunswick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Amsterdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. David","family":"Mozley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Newberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R16010CIHICDJG","doi-asserted-by":"crossref","unstructured":"Kapur S, Mann JJ: Role of the dopaminergic system in depression. Biol Psychiatry 1992; 32:1\u201317","DOI":"10.1016\/0006-3223(92)90137-O"},{"key":"R16010CIHHCAAI","doi-asserted-by":"crossref","unstructured":"D\u2019Aquila PS, Collu M, Cessa GL, Serra G: The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 2000; 405:365\u2013373","DOI":"10.1016\/S0014-2999(00)00566-5"},{"key":"R16010CIHICCGG","doi-asserted-by":"crossref","unstructured":"Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM: Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res 1985; 15:281\u2013292","DOI":"10.1016\/0165-1781(85)90065-4"},{"key":"R16010CIHDEGEA","doi-asserted-by":"crossref","unstructured":"Bowden C, Cheetham SC, Lowther S, Katona CLE, Crompton MR, Horton RW: Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 1997; 769:135\u2013140","DOI":"10.1016\/S0006-8993(97)00692-6"},{"key":"R16010CIHFBFIC","doi-asserted-by":"crossref","unstructured":"Lambert G, Johansson M, Agren H, Friberg P: Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 2000; 57:787\u2013793","DOI":"10.1001\/archpsyc.57.8.787"},{"key":"R16010CIHIJCEE","doi-asserted-by":"crossref","unstructured":"Cummings JL: Depression and Parkinson\u2019s disease: a review. Am J Psychiatry 1992; 149:443\u2013454","DOI":"10.1176\/ajp.149.4.443"},{"key":"R16010CIHJCJHG","doi-asserted-by":"crossref","unstructured":"Rogers MA, Bradshaw JL, Pantelis C, Phillips JG: Frontostriatal deficits in unipolar major depression. Brain Res Bull 1998; 47:297\u2013310","DOI":"10.1016\/S0361-9230(98)00126-9"},{"key":"R16010CIHJFJEJ","unstructured":"McHugh PR: The neuropsychiatry of basal ganglia disorders: a triadic syndrome and its explanation. Neuropsychiatry Neuropsychol Behav Neurol 1989; 2:239\u2013247"},{"key":"R16010CIHJFEAE","doi-asserted-by":"crossref","unstructured":"Acton PD, Mozley PD: Single photon emission tomography imaging in parkinsonian disorders: a review. Behav Neurol 1999; 12:11\u201327","DOI":"10.1155\/2000\/914154"},{"key":"R16010CIHCJBFE","doi-asserted-by":"crossref","unstructured":"Lenze E, Cross D, McKeel D, Neuman RJ, Sheline YI: White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry 1999; 156:1602\u20131607","DOI":"10.1176\/ajp.156.10.1602"},{"key":"R16010CIHIBJGF","doi-asserted-by":"crossref","unstructured":"Krishnan KR, McDonald WM, Escalona PR, Doraiswamy PM, Na C, Husain MM, Figiel GS, Boyko OB, Ellinwood EH, Nemeroff CB: Magnetic resonance imaging of the caudate nuclei in depression: preliminary observations. Arch Gen Psychiatry 1992; 49:553\u2013557","DOI":"10.1001\/archpsyc.1992.01820070047007"},{"key":"R16010CIHFJBJA","doi-asserted-by":"crossref","unstructured":"Parashos IA, Tupler LA, Blitchington T, Krishnan KR: Magnetic-resonance morphometry in patients with major depression. Psychiatry Res Neuroimaging 1998; 84:7\u201315","DOI":"10.1016\/S0925-4927(98)00042-0"},{"key":"R16010CIHFBBEE","doi-asserted-by":"crossref","unstructured":"Soares JC, Mann JJ: The functional neuroanatomy of mood disorders. J Psychiatr Res 1997; 31:393\u2013432","DOI":"10.1016\/S0022-3956(97)00016-2"},{"key":"R16010CIHIBBGF","doi-asserted-by":"crossref","unstructured":"Kennedy SH, Evans KR, Kr\u00fcger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ: Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001; 158:899\u2013905","DOI":"10.1176\/appi.ajp.158.6.899"},{"key":"R16010CIHIIIDB","doi-asserted-by":"crossref","unstructured":"Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001; 58:631\u2013640","DOI":"10.1001\/archpsyc.58.7.631"},{"key":"R16010CIHGACBE","unstructured":"Arnt J, Hyttel J, Overo KF: Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions. Pol J Pharmacol Pharm 1984; 36:221\u2013230"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Maj J, Rogoz Z: Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha(1)-adrenergic, dopamine and serotonin systems. J Neural Transm 1999; 106:197\u2013211","DOI":"10.1007\/s007020050151"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Maj J, Dziedzicka-Wasylewska M, Rogoz R, Rogoz Z: Effect of antidepressant drugs administered repeatedly on the dopamine D-3 receptors in the rat brain. Eur J Pharmacol 1998; 351:31\u201337","DOI":"10.1016\/S0014-2999(98)00297-0"},{"key":"R16010CIHDBHCJ","doi-asserted-by":"crossref","unstructured":"Plaznik A, Kostowski W: The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur J Pharmacol 1987; 135:389\u2013396","DOI":"10.1016\/0014-2999(87)90689-3"},{"key":"R16010CIHIDCFG","doi-asserted-by":"crossref","unstructured":"Kung MP, Stevenson DA, Plossl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF: [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24:372\u2013380","DOI":"10.1007\/BF00881808"},{"key":"R16010CIHGFIDF","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56\u201362","DOI":"10.1136\/jnnp.23.1.56"},{"key":"R16010CIHDGDAB","doi-asserted-by":"crossref","unstructured":"Brunswick DJ, Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Beasley CM Jr: Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy. J Clin Psychopharmacol 2001; 21:616\u2013618","DOI":"10.1097\/00004714-200112000-00014"},{"key":"R16010CIHHHEGD","unstructured":"Mozley PD, Schneider JS, Acton PD, Plossl K, Stern MB, Siderowf A, Leopold NA, Li PY, Alavi A, Kung HF: Binding of [Tc-99m]TRODAT-1 to dopamine transporters in patients with Parkinson\u2019s disease and in healthy volunteers. J Nucl Med 2000; 41:584\u2013589"},{"key":"R16010CIHIJCEF","doi-asserted-by":"crossref","unstructured":"Mozley LH, Gur RC, Mozley PD, Gur RE: Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 2001; 158:1492\u20131499","DOI":"10.1176\/appi.ajp.158.9.1492"},{"key":"R16010CIHFCAIH","doi-asserted-by":"crossref","unstructured":"Acton PD, Meyer PT, Mozley PD, Plossl K, Kung HF: Simplified quantification of dopamine transporters in humans using [Tc-99m]TRODAT-1 and single-photon emission tomography. Eur J Nucl Med 2000; 27:1714\u20131718","DOI":"10.1007\/s002590000371"},{"key":"R16010CIHHCCGD","doi-asserted-by":"crossref","unstructured":"Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J: Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) 1999; 144:282\u2013285","DOI":"10.1007\/s002130051005"},{"key":"R16010CIHIHAHE","doi-asserted-by":"crossref","unstructured":"Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS: Reduced brain serotonin transporter availability in major depression as measured by [123I]-2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 1998; 44:1090\u20131098","DOI":"10.1016\/S0006-3223(98)00272-8"},{"key":"R16010CIHEBDFC","doi-asserted-by":"crossref","unstructured":"Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG: Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 1998; 95:4029\u20134034","DOI":"10.1073\/pnas.95.7.4029"},{"key":"R16010CIHFBGIB","unstructured":"Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ: Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J Pharmacol Exp Ther 2001; 298:129\u2013140"},{"key":"R16010CIHBIGEA","doi-asserted-by":"crossref","unstructured":"Caligiuri MP, Ellwanger J: Motor and cognitive aspects of motor retardation in depression. J Affect Disord 2000; 57:83\u201393","DOI":"10.1016\/S0165-0327(99)00068-3"},{"key":"R16010CIHHAHHG","doi-asserted-by":"crossref","unstructured":"Sachdev P, Aniss AM: Slowness of movement in melancholic depression. Biol Psychiatry 1994; 35:253\u2013262","DOI":"10.1016\/0006-3223(94)91256-4"},{"key":"R16010CIHJGADC","doi-asserted-by":"crossref","unstructured":"Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS: Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997; 54:364\u2013374","DOI":"10.1001\/archpsyc.1997.01830160092012"},{"key":"R16010CIHICIIF","doi-asserted-by":"crossref","unstructured":"Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ: Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 1999; 174:525\u2013529","DOI":"10.1192\/bjp.174.6.525"},{"key":"R16010CIHDEEAG","doi-asserted-by":"crossref","unstructured":"George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM: Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 1995; 152:341\u2013351","DOI":"10.1176\/ajp.152.3.341"},{"key":"R16010CIHCHBFF","doi-asserted-by":"crossref","unstructured":"Byrum CE, Ahearn EP, Krishnan KR: A neuroanatomic model for depression. Prog Neuropsychopharmacol 1999; 23:175\u2013193","DOI":"10.1016\/S0278-5846(98)00106-7"},{"key":"R16010CIHHFEID","doi-asserted-by":"crossref","unstructured":"Drevets WC: Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126:413\u2013431","DOI":"10.1016\/S0079-6123(00)26027-5"},{"key":"R16010CIHHCBFC","doi-asserted-by":"crossref","unstructured":"Larisch R, Meyer W, Klimke A, Kehren F, Vosberg H, Muller-Gartner HW: Left-right asymmetry of striatal dopamine D-2 receptors. Nucl Med Commun 1998; 19:781\u2013787","DOI":"10.1097\/00006231-199808000-00009"},{"key":"R16010CIHGCCHD","doi-asserted-by":"crossref","unstructured":"Lammers CH, D\u2019Souza U, Qin ZH, Lee SH, Yajima S, Mouradian MM: Regulation of striatal dopamine receptors by estrogen. Synapse 1999; 34:222\u2013227","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<222::AID-SYN6>3.3.CO;2-A"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.10.1836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:02:43Z","timestamp":1722380563000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.10.1836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10,1]]}},"alternative-id":["10.1176\/appi.ajp.160.10.1836"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.10.1836","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}